Skip to main content

Court Urged to Reinstate Dismissed Paraquat Bellwether Cases

Court Urged to Reinstate Dismissed Paraquat Bellwether Cases

Court Urged to Reinstate Dismissed Paraquat Bellwether Cases

Introduction

The Seventh Circuit Court of Appeals is considering whether to reinstate four Paraquat lawsuits that were previously dismissed.

These cases were originally selected for the first federal bellwether trials to examine potential links between the weedkiller and Parkinson’s disease. However, the trial judge dismissed them last year after barring the plaintiffs’ expert witnesses from testifying.

Background of Paraquat Litigation

These lawsuits are part of a broader legal battle against Syngenta and Chevron, with over 5,800 product liability claims filed in federal court. Plaintiffs allege that the manufacturers failed to warn users about the increased risk of Parkinson’s disease linked to Paraquat exposure. Since June 2021, the cases have been centralized in a multidistrict litigation (MDL) in the Southern District of Illinois to streamline pretrial proceedings and prepare representative cases for bellwether trials.

Dismissal of Bellwether Cases and Appeal

Despite the judge’s initial selection of bellwether cases, the first group was dismissed after expert testimony was excluded. This left the plaintiffs unable to prove that their Parkinson’s disease resulted from Paraquat exposure. The plaintiffs appealed the decision, arguing that their experts were unfairly held to an excessively high standard and that the ruling was premature. They claim the judge’s assessment of their testimony exceeded legal precedents and that a jury should have determined the reliability of the evidence.

Defendants’ Position

Syngenta and Chevron continue to deny the allegations, asserting that no peer-reviewed research has definitively linked Paraquat to Parkinson’s disease. They maintain that the plaintiffs’ claims lack scientific support and should be dismissed.

New Bellwether Cases Moving Forward

While the appeal is pending, the judge overseeing the MDL has moved forward with a second batch of bellwether cases. In August 2024, 10 new cases were selected, and in January 2025, six of those cases were chosen for full case-specific discovery. Three cases are set for the first bellwether trial on October 14, 2025, while the remaining three will go to trial on April 6, 2026.

Potential Impact of Bellwether Trials

Although these bellwether trials will not have a binding effect on other cases, their outcomes will likely influence settlement negotiations. If plaintiffs win, Syngenta and Chevron may be pressured to offer settlements to avoid costly individual trials across the country. Conversely, if the defendants prevail, it could weaken the broader litigation efforts.

Significance of the Appeal’s Outcome

As the legal proceedings continue, the Seventh Circuit’s ruling on whether to reinstate the dismissed cases could significantly impact the direction of the Paraquat litigation. The decision may shape how courts handle expert witness testimony and determine the strength of similar claims in the future.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Walgreens Settles Federal Opioid Case for $300 Million

Categories: Opioids

Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.

The U.S. Department of Justice announced on Monday…

Study: Opioid Use in Pregnancy May Shrink Newborn Brains

Categories: Opioids

New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…

Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting

Categories: Opioids

The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…

🛠️ You Have Unfinished Work. We’ll Finish It — Free Trial.            
Free Trial + 25% Off All DLs & Med Review Case Backlog!

Only 12 Firms Can Join – First Come, First Served